Hovione Farmaciencia Sa, based in Portugal, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BETAMETHASONE SODIUM PHOSPHATE, with a corresponding US DMF Number 6687.
Remarkably, this DMF maintains an Active status since its submission on November 18, 1986, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 18, 2013, and payment made on December 14, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II